O’Leary-Sant Symptom Index Predicts the Treatment Outcome for Onabotulinumtoxin A Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome

Although intravesical injection of onabotulinumtoxinA (BoNT-A) has been proved promising in treating patients with interstitial cystitis/bladder pain syndrome (IC/BPS), what kind of patients that may benefit from this treatment remains unclear. This study investigated the predictors for a successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yuh-Chen, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549729/
https://www.ncbi.nlm.nih.gov/pubmed/26264022
http://dx.doi.org/10.3390/toxins7082860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549729/
https://www.ncbi.nlm.nih.gov/pubmed/26264022
http://dx.doi.org/10.3390/toxins7082860

Ejemplares similares